Dominance of IL-12 over IL-4 in gamma delta T cell differentiation leads to default production of IFN-gamma: failure to down-regulate IL-12 receptor beta 2-chain expression.

Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Dominance of IL-12 over IL-4 in gamma delta T cell differentiation leads to default production of IFN-gamma: failure to down-regulate IL-12 receptor beta 2-chain expression.

J Immunol. 2000 Mar 15;164(6):3056-64. Unique Identifier : AIDSLINE MED/20171504
Yin Z; Zhang DH; Welte T; Bahtiyar G; Jung S; Liu L; Fu XY; Ray A; Craft J; Sections of Rheumatology and Pulmonary and Critical Care; Medicine, Department of Medicine, Department of Pathology, and; Section of Immunobiology, Yale School of Medicine, New Haven, CT; 06520, USA.

Abstract: Gamma delta T cells secrete Th1- and Th2-like cytokines that help mediate innate and acquired immunity. We have addressed the mechanism whereby murine gamma delta T cells acquire the capacity to differentially produce such cytokines. Splenic gamma delta T cells could be polarized into IFN-gamma- or IL-4-secreting cells in vitro; however, in contrast to CD4+ alpha beta T cells, gamma delta T cells predominantly produced IFN-gamma, even in the presence of IL-4, a finding independent of genetic background. Like CD4+ Th1 cells, IFN-gamma-producing cells expressed the IL-12 receptor beta 2-chain after activation in the presence of IL-12; however, unlike Th2 cells, IL-4-primed gamma delta T cells also expressed this receptor, even in the absence of IFN-gamma and despite the presence of the transcription factor GATA-3. IL-12 also induced IL-4-primed gamma delta T cells to proliferate and to translocate Stat3/Stat4, indicating signaling through the IL-12 receptor. These molecular events can account for the predominant production of IFN-gamma by gamma delta T cells in the presence of IL-12, despite the availability of IL-4. Early and predominant production of IFN-gamma by gamma delta T cells likely is critical for the roles that these cells play in protection against intracellular pathogens and in tumor immunity.

Keywords: JOURNAL ARTICLE Animal Cell Differentiation/IMMUNOLOGY Cells, Cultured Cytokines/BIOSYNTHESIS Down-Regulation (Physiology)/*IMMUNOLOGY DNA-Binding Proteins/PHYSIOLOGY Interferon Type II/*BIOSYNTHESIS/SECRETION Interleukin-12/METABOLISM/*PHYSIOLOGY Interleukin-4/BIOSYNTHESIS/*PHYSIOLOGY Lymphocyte Transformation Mice Mice, Inbred BALB C Mice, Inbred C57BL Receptors, Antigen, T-Cell, gamma-delta/*METABOLISM Receptors, Interleukin/ANTAGONISTS & INHIB/*BIOSYNTHESIS Signal Transduction/IMMUNOLOGY Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. T-Lymphocyte Subsets/CYTOLOGY/*IMMUNOLOGY/*METABOLISM/SECRETION Th1 Cells/IMMUNOLOGY/METABOLISM Th2 Cells/IMMUNOLOGY/METABOLISM Trans-Activators/PHYSIOLOGY

000630
A0061913

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .